Online TRT in Delaware 2026 Every Provider Compared, Ranked, and Priced

Good news if you are in Delaware: all 6 major online testosterone replacement therapy providers accept patients in your state. That is not a guarantee you get in every state. Some smaller or more restrictive states see providers like Maximus or DudeMeds pull back due to controlled-substance telehealth regulations, but Delaware operates under standard federal DEA rules and none of the six have restricted access here. The full list is Maximus, DudeMeds, Peter MD, Taurus Meds, Hims, and Fridays.

Two of those six are genuinely built around TRT as their primary service: Maximus and Peter MD. The rest, including Hims, Fridays, DudeMeds, and Taurus Meds, treat testosterone optimization as one service among several that include ED, hair loss, and weight loss.

For Delaware residents doing this research in 2026, the practical decision comes down to three things: what form of testosterone you want (injections, gels, or alternatives like enclomiphene), what you are willing to pay monthly, and whether you want a provider whose entire clinical model is built around hormone optimization or one that handles testosterone alongside ten other men's health categories. Both approaches work. The right one depends on your situation.

Testosterone is a Schedule III controlled substance under federal law, and that classification shapes exactly how any Delaware provider can prescribe it to you via telehealth. The DEA's telemedicine rules require that before a controlled substance is prescribed, you must have a legitimate patient-provider relationship established through a proper medical evaluation. Every TRT provider operating in Delaware, whether Maximus, DudeMeds, or Peter MD, will require you to complete an intake consultation and, critically, submit recent blood work before a prescription is written.

Delaware does not add state-level restrictions on top of the federal framework that would make getting TRT harder here than in, say, Texas or Florida. You will not hit a state-mandated in-person visit requirement for testosterone specifically. That said, the federal rule still means there is no pathway to skipping the lab step. Any provider advertising same-day testosterone delivery without lab work should be a red flag. Legitimate providers in Delaware will either require you to upload existing labs (usually within 90 days) or order a test kit to your Delaware address before the prescription is issued.

The medications available to Delaware residents through these platforms include testosterone cypionate injections, testosterone enanthate, testosterone gels and creams, and off-label options like clomiphene and enclomiphene. Testosterone pellets are less common through telehealth because they require an in-office insertion procedure, but some providers like Peter MD can connect you with local partners for that route if you prefer a longer-acting format and are not opposed to an in-person visit at a Delaware-area clinic.

Maximus earns its 9.2/10 rating by doing one thing well: testosterone optimization protocols for men. This is not a platform where a doctor glances at your testosterone levels between ED and hair loss consultations. The entire clinical model at Maximus is built around what they call testosterone optimization, which means your protocol, your follow-up, and your dose adjustments are all handled by physicians who treat hormone health as a specialty rather than a line item.

For Delaware residents, Maximus operates entirely via telehealth with no requirement to visit a physical location. You complete your intake, order or submit labs, and a physician reviews your numbers and medical history before building a protocol. They work with testosterone cypionate as their primary injectable option, which is the most widely used and cost-stable form of testosterone in the US. Their pricing is subscription-based and on the mid-to-upper end of what you will find across these six providers, but the clinical depth justifies that for men who want active physician oversight rather than a set-and-forget prescription.

Maximus carries the 'Top Rated' designation in this category, and it is one of the two providers here built around testosterone as a primary service rather than one item in a broader catalog. If you are a Delaware resident who has already done some research and knows you want injectable testosterone with real clinical oversight and the ability to adjust your protocol over time rather than getting a static prescription, Maximus is the clearest starting point on this list.

DudeMeds holds a 9.2/10 rating, reflecting its combination of strong pricing, broad men's health coverage, and a telehealth experience that moves quickly from sign-up to prescription. For Delaware residents who are new to TRT or who want to start with testosterone as part of a broader men's health assessment that might also include ED or hair loss, DudeMeds makes that multi-condition approach easy. You are not forced to open separate accounts across different platforms for each concern.

Peter MD sits at 9.5/10 and keeps its TRT pricing competitive. If you are a Delaware resident primarily motivated by keeping monthly costs manageable, Peter MD's physician-led TRT protocols come in at pricing that consistently undercuts the mid-to-upper-range platforms without sacrificing the medically supervised structure that legitimate TRT requires. Their coverage also includes ED, weight loss, and hair loss, so like DudeMeds, there is flexibility to address multiple issues through one provider relationship.

The practical difference between DudeMeds and Peter MD for a Delaware patient mostly comes down to volume of reviews and current promotional positioning. DudeMeds is the cheaper of the two at $77 a month against Peter MD's $79, which makes DudeMeds the better pick if cost is your primary filter. Either one will require the same lab work and evaluation process before prescribing testosterone, because Delaware's controlled-substance framework applies equally to every platform.

Hims sits at 9.4/10, but its TRT offering is not the core of what Hims does. Hims built its reputation and its scale on ED medications, hair loss treatments, and mental health support. Testosterone replacement is available through Hims in Delaware, but if optimizing your hormone levels is your primary goal rather than a secondary add-on to other treatments, you will be working within a platform that is not architecturally designed for that focus. Where Hims stands out for Delaware users is its mobile experience and its pricing on generic medications, which is genuinely aggressive.

Fridays offers something slightly different: injectable testosterone from $129 per month with a free biomarker assessment through Quest or LabCorp, plus enclomiphene from $169 per month. For Delaware residents who want to see the price of each piece of the protocol before committing, Fridays' transparent, itemized pricing and free shipping stand out from platforms that bundle TRT into a broader subscription.

Taurus Meds is the highest-rated option on this page at 9.6/10, and at $149 a month it is also the most expensive of the six. It covers ED, PE, and hair loss alongside testosterone, and it carries the Our Top Choice designation in this category. For a Delaware resident who wants the strongest review record and is not filtering on price, Taurus Meds is worth comparing. If cutting your ongoing cost is the goal instead, DudeMeds at $77 and Peter MD at $79 are the two to price out. For someone starting from scratch with no prior TRT history and wanting clinical depth, the more specialized platforms will serve you better.

Pricing across these six Delaware-available providers runs from $77 to $149 a month. DudeMeds anchors the low end at $77 and Peter MD is $2 behind at $79. Hims and Maximus sit in the middle at $99 and $99.99. Fridays is $129, and Taurus Meds is the most expensive of the six at $149. Those are the platform prices, so what you actually pay on top of them depends on which protocol and add-ons you select.

Those numbers reflect ongoing monthly subscription costs and typically include the medication, but you need to factor in the upfront lab work cost if you do not have recent bloodwork. Most Delaware providers will either have you use a third-party lab like Quest Diagnostics or LabCorp (both have locations throughout Delaware, including Wilmington, Dover, and Newark) or mail you an at-home test kit. Lab costs range from about $50 on the low end for a basic testosterone panel to $150 to $200 for a full hormonal panel including free and total testosterone, LH, FSH, estradiol, CBC, and metabolic markers. Some providers bundle the initial lab cost into their sign-up fee.

One pricing reality specific to Delaware residents: because Delaware is a small state with no in-network TRT clinic infrastructure compared to larger metro areas, nearly all TRT is priced on a cash-pay basis through these platforms. That is not necessarily a disadvantage since telehealth pricing is frequently lower than what you would pay out-of-pocket at a Delaware-based men's health clinic or urology practice without insurance coverage for TRT. The per-vial cost of testosterone cypionate through telehealth providers tends to be competitive with local pharmacy pricing, especially when factoring in compound pharmacy partnerships some platforms maintain.

Delaware's insurance market is dominated by carriers including Highmark Blue Cross Blue Shield of Delaware, Aetna, Cigna, and United Healthcare. None of these carriers offer blanket TRT coverage as a guaranteed benefit, but many Delaware residents with employer-sponsored insurance can get testosterone covered if the prescribing physician documents hypogonadism as a clinical diagnosis with supporting lab work. The threshold most insurance companies use is a total testosterone level below 300 ng/dL alongside clinical symptoms, though the diagnostic standard varies by carrier.

Among the six providers available in Delaware, insurance navigation support varies. Platforms like Maximus and DudeMeds operate predominantly on a cash-pay subscription model, while Peter MD offers some insurance engagement depending on your specific plan and the diagnosis pathway.

For most Delaware residents, the honest answer is that TRT through telehealth will be an out-of-pocket expense, at least initially. If your testosterone levels are borderline rather than clinically low, insurance is unlikely to cover it regardless of which platform you use or which Delaware insurer you have. If your levels are genuinely low and you have a qualifying diagnosis, working with your primary care physician or an endocrinologist at a Delaware-based practice like Christiana Care's endocrinology department alongside a telehealth provider can sometimes create a documentation pathway that supports insurance claims. But most men using these platforms do so on a self-pay basis and find the monthly cost reasonable compared to traditional clinic visits.

Testosterone cypionate injections are the most commonly prescribed form of TRT through every platform serving Delaware. Cypionate has a longer half-life than enanthate, which means weekly or biweekly injections rather than more frequent dosing, and its cost is stable because it is widely available as a generic. For Delaware residents who are comfortable self-injecting subcutaneously (under the skin rather than intramuscular, which is what most telehealth protocols now use), cypionate is straightforward to use at home. Providers ship supplies including syringes and injection pads to Delaware addresses, typically within a few days of prescription approval.

Enclomiphene is a meaningful alternative worth understanding if you are a Delaware resident in your 30s or early 40s who is concerned about fertility. Traditional TRT suppresses your body's own testosterone production and reduces sperm count because exogenous testosterone signals the brain to stop producing LH and FSH. Enclomiphene works differently: it blocks estrogen receptors in the hypothalamus, which causes the brain to increase its own signaling to the testes rather than bypassing that system entirely. The result is higher testosterone levels without the fertility suppression that comes with injections or gels. Maximus, Peter MD, and DudeMeds all offer enclomiphene as an off-label but physician-supervised option for Delaware patients.

Testosterone gels and creams are available through most platforms but are less common as a starting recommendation in 2026 because of transfer risk (accidental contact with partners or children), the need for daily application rather than weekly injection, and slightly less predictable absorption. Pellets are the least common telehealth-compatible option because the insertion procedure requires a physical visit. If you are in Delaware and want pellets, you would typically need to locate a Delaware-based men's health clinic or urology practice that offers them, and use a telehealth platform primarily for initial evaluation and monitoring.

If you want the most clinically focused TRT experience available in Delaware and are comfortable paying mid-range pricing for physician oversight that is specifically built around hormone optimization, start with Maximus. Its 9.2/10 rating is earned by a clinical model that treats testosterone seriously rather than as a sidebar to ED prescriptions. The telehealth process works entirely within Delaware's regulatory framework, the lab work process is clear, and you will not hit a wall because of state-specific restrictions.

If you want the most value-optimized path to a legitimate TRT prescription in Delaware and your monthly budget is the deciding factor, Peter MD is worth a close look. The physician-led protocols are medically sound, the pricing undercuts most competitors, and the coverage is broad enough to address other men's health issues if they come up.

If you are newer to telehealth and want a large, well-reviewed platform with a strong mobile experience as you sort out whether TRT is right for you, DudeMeds or Hims are both solid starting points for a Delaware resident. Hims rates 9.4/10 and DudeMeds 9.2/10, both operate cleanly in Delaware, and both offer the consultation-first approach that federal DEA rules require anyway. The difference is that DudeMeds leans more toward men's health broadly while Hims has deeper roots in hair loss and ED. For a TRT-specific search, DudeMeds has the edge. For someone managing multiple men's health concerns simultaneously and wanting one platform to handle all of them, Hims is worth considering given its scale and mobile-first design.